>>> US Research Calls



From: update@briefing.com At: 04/01/22 13:26:27 UTC+2:00
To: Laurent Chekroun (MAKOR CAPITAL MARKET )
Subject: Briefing; CALLS; Research Calls

Briefing.com Logo
01-Apr-22 07:26 ET

TICKER ALERT: CALLS

Research Calls

  • Upgrades:
    • Banco Santander (SAN) upgraded to Outperform from Neutral at Credit Suisse
    • Caixabank (CAIXY) upgraded to Outperform from Neutral at Credit Suisse
    • Centennial Resource Development (CDEV) upgraded to Buy from Hold at Stifel; tgt raised to $11.20
    • Comerica (CMA) upgraded to Neutral from Sell at Goldman; tgt raised to $112
    • Comerica (CMA) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $115
    • Evotec SE (EVO) upgraded to Buy from Neutral at Kempen; tgt $15
    • Tellurian (TELL) upgraded to Outperform from Neutral at Credit Suisse; tgt raised to $8
    • Vertiv (VRT) upgraded to Overweight from Neutral at JP Morgan; tgt lowered to $18
  • Downgrades:
    • Amylyx Pharmaceuticals (AMLX) downgraded to Neutral from Buy at Goldman; tgt lowered to $10
    • American Eagle (AEO) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $19
    • BankUnited (BKU) downgraded to Neutral from Overweight at JP Morgan; tgt $50
    • Blend Labs (BLND) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $5
    • Blend Labs (BLND) downgraded to Hold from Buy at Canaccord Genuity; tgt lowered to $5
    • Blend Labs (BLND) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $5.50
    • Commscope (COMM) downgraded to Neutral from Buy at Goldman; tgt lowered to $9
    • Dell (DELL) downgraded to Neutral from Conviction Buy at Goldman; tgt lowered to $61
    • Ellington Residential Mtg (EARN) downgraded to Mkt Perform from Mkt Outperform at JMP Securities
    • First American Financial (FAF) downgraded to Neutral from Outperform at Credit Suisse; tgt lowered to $74
    • Gap (GPS) downgraded to Underweight from Equal Weight at Barclays; tgt lowered to $13
    • NextDecade (NEXT) downgraded to Neutral from Outperform at Credit Suisse; tgt raised to $7.50
    • Poshmark (POSH) downgraded to Hold from Buy at Stifel; tgt lowered to $15
    • Qorvo (QRVO) downgraded to Neutral from Outperform at KGI Securities; tgt $140
    • Science Applications (SAIC) downgraded to Hold from Buy at Truist; tgt $105
    • Silverback Therapeutics (SBTX) downgraded to Hold from Buy at Stifel; tgt lowered to $6
    • Silverback Therapeutics (SBTX) downgraded to Neutral from Buy at H.C. Wainwright
    • UniFirst (UNF) downgraded to Underweight from Neutral at JP Morgan; tgt $178
    • Urban Outfitters (URBN) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $29
    • Walgreens Boots Alliance (WBA) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $51
    • Wayfair (W) downgraded to Underweight from Equal Weight at Barclays; tgt $103
    • Zimmer Biomet (ZBH) downgraded to Neutral from Buy at Citigroup; tgt raised to $135
  • Others:
    • 1Life Healthcare (ONEM) assumed with an Outperform at Credit Suisse; tgt $15
    • Accolade (ACCD) assumed with an Outperform at Credit Suisse; tgt $33
    • Agree Realty (ADC) initiated with an Overweight at Morgan Stanley; tgt $75
    • AmerisourceBergen (ABC) assumed with an Outperform at Credit Suisse; tgt $180
    • Amwell (AMWL) assumed with a Neutral at Credit Suisse; tgt $5
    • Cano Health (CANO) assumed with an Outperform at Credit Suisse; tgt $13
    • Cardinal Health (CAH) assumed with a Neutral at Credit Suisse; tgt $58
    • Change Healthcare (CHNG) assumed with a Neutral at Credit Suisse; tgt $25.75
    • Check Point Software (CHKP) initiated with a Buy at Summit Insights; tgt $160
    • Definitive Healthcare (DH) assumed with a Neutral at Credit Suisse; tgt $24
    • eHealth (EHTH) assumed with a Neutral at Credit Suisse; tgt $16
    • Edwards Lifesciences (EW) added to Focus List at Citigroup
    • GoHealth (GOCO) assumed with an Underperform at Credit Suisse; tgt $1.50
    • GoodRx (GDRX) assumed with a Neutral at Credit Suisse; tgt $22
    • Hims & Hers Health (HIMS) assumed with an Outperform at Credit Suisse; tgt $8
    • ImaRx Therapeutics (IMRX) initiated with an Outperform at Oppenheimer; tgt $25
    • McKesson (MCK) assumed with an Outperform at Credit Suisse; tgt $333
    • MSCI (MSCI) initiated with a Neutral at Goldman; tgt $553
    • Oracle (ORCL) initiated with a Neutral at Daiwa Securities; tgt $87
    • Owens & Minor (OMI) assumed with a Neutral at Credit Suisse; tgt $43
    • Premier (PINC) assumed with an Underperform at Credit Suisse; tgt $35
    • Privia Health (PRVA) assumed with an Outperform at Credit Suisse; tgt $43
    • Rain Therapeutics (RAIN) initiated with an Outperform at Oppenheimer; tgt $15
    • SelectQuote (SLQT) assumed with a Neutral at Credit Suisse; tgt $4
    • Snowflake (SNOW) initiated with a Neutral at SMBC Nikko; tgt $253
    • SOC Telemed (TLMD) assumed with a Neutral at Credit Suisse; tgt $3
    • Teladoc (TDOC) assumed with an Outperform at Credit Suisse; tgt $114
    • Tivity Health (TVTY) assumed with a Neutral at Credit Suisse; tgt $31
    • Upstart (UPST) initiated with an Equal-Weight at Stephens; tgt $124
    • Vectrus (VEC) initiated with a Buy at Truist; tgt $65